ClaraScience logoClaraScienceResearch-Grade Peptides
Research Reference

Laboratory Peptide Documentation: How to Read HPLC USP Peak-Table Fields in Australia

Laboratory peptide documentation is only as useful as the ability of a receiving laboratory to read the HPLC peak table behind a printed purity percentage. Australian research groups often open a certificate of analysis (COA) that quotes an area-normalised purity figure without checking whether the main peak was symmetrical, whether the column still met efficiency criteria, or whether the principal component was resolved from the nearest related substance. Those checks live, when supplied, in USP-style peak-table columns: tailing factor (T), theoretical plates (N), resolution (Rs) and capacity factor (k′). This page is a field-by-field reading guide for those columns on research-grade peptide COAs. It does not address biological activity or human use. It treats the chromatogram as an experimental record. Local Australian stock, tracked dispatch and batch documentation bind the PDF to a physical vial; the peak-table fields then show whether that chromatogram was fit for identity and purity reporting.

Which USP-style columns appear in laboratory peptide documentation HPLC peak tables?

A complete HPLC peak table in laboratory peptide documentation is not the same object as the single purity percentage on the COA summary page. Chromatography data systems (Empower, Chromeleon, OpenLab) export a row for every integrated peak and calculated columns that the vendor may or may not transcribe. Columns that matter to a receiving laboratory are typically: peak number; peak name; retention time (tR); relative retention time (RRT); area; area percent; height; width at half height (w½); USP tailing factor (T); USP plate count (N); resolution (Rs) to the adjacent peak; and capacity factor (k′). Reading starts by confirming that the peak table belongs to the same sample as the COA header. Sample name, vial identifier, instrument identifier and acquisition time must concord with the lot on the vial label and the packing slip. A purity percentage without a peak table is a headline without a methods section. Structured reading of technical documents insists that results cannot be interpreted in isolation from the record that produced them (DOI:10.5694/j.1326-5377.1992.tb137249.x). Truncated vendor PDFs often retain only peak name, tR and area percent. That removes independent evidence that the system was suitable. If T, N, Rs and k′ are absent, a laboratory cannot distinguish a Gaussian main peak from a tailed or co-eluting envelope that still integrates to a reassuring area percent. Australian laboratories should list these USP-style columns in purchase specifications. Finding the relevant fields is a retrieval task as well as a chemistry task (DOI:10.3897/tdwgproceedings.1.19941).

How do you read USP tailing factor (T) on a peptide HPLC chromatogram?

USP tailing factor T is commonly calculated as T = W0.05 / 2f, where W0.05 is peak width at 5% of height and f is the distance from the leading edge to the perpendicular from the apex. T = 1.00 is symmetrical. Values above 1.00 describe tailing; values below 1.00 describe fronting. On peptide reversed-phase chromatograms, modest tailing is common because residual silanols, secondary ionic interactions and slow conformational interconversion broaden the rear slope. Fronting often indicates column overload or a sample solvent stronger than the starting mobile phase. Do not treat T as a purity number: it is a peak-shape diagnostic. A main-peak T of 1.1–1.5 with an SST limit of T ≤ 2.0 supports integration on a reasonably Gaussian profile. A main-peak T of 2.5–3.0 implies a long tail in which small related substances can hide, so area-percent purity may be optimistic. A T of 0.7 with visible fronting should trigger checks of load mass, sample-solvent strength and column capacity before the purity figure is copied into a notebook. Compare T for the main peak with T for the nearest related substance. If the impurity is sharp (T ≈ 1.0) while the main peak is badly tailed, the main-peak area is the less trustworthy integrator. Record the SST limit and whether the sample chromatogram, not only the SST mixture, meets it. Experimental records mislead when a summary statistic is read without the shape information that qualifies it (DOI:10.1002/asi.5090180408). How a text is read determines what the reader thinks has been shown; the same caution applies to chromatograms (DOI:10.5840/acpq199569241).

How should theoretical plates (N) and capacity factor (k′) be read on a peptide COA?

Theoretical plates N quantify apparent column efficiency for a given peak. The common CDS formula is N = 5.54 (tR / w½)² using width at half height. N is not a property of the peptide; it is a property of that peak in that method on that column at that time. Short peptides on a 150 mm, 3 µm C18 column may show N in the tens of thousands; larger or conformationally heterogeneous peptides often show lower N because extra-column dispersion and slow desorption broaden the peak. Compare reported N with the SST limit (for example N ≥ 2000). Capacity factor k′ is (tR − t0) / t0. A main peak with k′ < 1 elutes near the solvent front; area-percent purity is then vulnerable to diluent peaks, salts and unretained truncations. A main peak with k′ > 15 is excessively retained, often as a broad envelope sensitive to baseline drift. Conventional isocratic practice keeps k′ roughly between 2 and 10; gradient methods replace a single k′ with a gradient retention factor, but many peptide COAs still print k′ from observed tR and an estimated t0. High N at k′ ≈ 0.5 is not evidence of a good identity method; the peak is sharp because it is barely retained. Low N at k′ ≈ 8 with T ≈ 1.2 may still be acceptable if Rs to the nearest related substance is adequate. Tabulated results invite false precision unless each column has an interpretation method (DOI:10.7816/ulakbilge-05-15-06).

How do HPLC USP peak-table fields relate to the COA purity percentage?

Area-percent purity on a peptide COA is almost always a normalised chromatographic purity: main-peak area divided by the sum of integrated peak areas above a reporting threshold, after excluding solvent and diluent peaks. It is not an assay against a qualified reference standard and it is not net peptide content. T, N, Rs and k′ do not change that arithmetic; they tell the reader whether the peaks were fit to integrate. A practical reading sequence is: (1) confirm lot, sample name and acquisition time; (2) confirm reporting wavelength and solvent-peak exclusion; (3) read k′ of the main peak; (4) read T against the SST limit; (5) read N against the SST limit; (6) read the smallest Rs involving the main peak; (7) only then copy area-percent purity into the notebook, annotated with those four values. If any SST field fails, the purity percentage was generated under unsuitable conditions and should be flagged. High area-percent purity with T > 2.5 and Rs < 1.2 is a warning that a related substance may sit in the main-peak tail. Low area-percent purity with excellent T, N and Rs is chemically more informative: related substances are resolved and quantified. A COA that reports a specification of purity ≥ 98% and a result of 99.2% but prints no peak table cannot be reconciled. Reading well means refusing a conclusion the record does not support (DOI:10.5840/acpq201488110). State which chromatogram supplied the USP fields; a high load-mass related-substances run will worsen T and N relative to an analytical-load purity run.

What lot-traceability checks should Australian laboratories apply when reading HPLC COA files?

Peak-table literacy is wasted if the chromatogram is not that of the vial on the bench. Before interpreting T, N, Rs or k′, match four identifiers: lot on the vial label; lot on the COA header; sample name in the HPLC sequence table; and lot on the packing slip from tracked dispatch. For multi-vial lots, confirm the COA sample identifier corresponds to the shared lot rather than another campaign. A research COA should carry an analyst identifier, acquisition date-time, processing-method name or version, and reviewer sign-off. Without a processing-method version, integration events, baseline type (linear, force, exponential) and peak-detection thresholds cannot be reproduced, and all of T, N, Rs and area percent can move. A screenshot chromatogram with no peak table is an illustration, not laboratory peptide documentation. Archive a complete PDF or native CDS report that includes column dimensions, particle size, mobile-phase A/B, gradient table, flow rate, oven temperature, detection wavelength and bandwidth, load volume and diluent. T = 1.8 on a 50 mm, 5 µm column at high load mass is a different story from T = 1.8 on a 150 mm, 2.6 µm core-shell column at an analytical load. Apply a written reading protocol rather than a glance at purity: identifiers concordant; SST limits stated; T, N, Rs and k′ present and inside limits; area-percent arithmetic described; mass-identity data present; anomalies flagged. Documentation is operational only when finding steps are written down (DOI:10.3897/tdwgproceedings.1.19941). Close reading of experimental material is a trained procedure (DOI:10.1002/asi.5090180408).

Apply this checklist to documented stock

You now have a practical way to read purity figures, method notes, and lot traceability. When you source materials, hold suppliers to that same checklist — ClaraScience issues batch documentation with every order and dispatches from Australian warehouses with Express tracked shipping.

Start with a retail order to review documentation end-to-end, or register for wholesale if you restock multiple compounds.

Frequently asked questions

What is the difference between HPLC area-percent purity and USP tailing factor on a peptide COA?

Area-percent purity is a normalised ratio of integrated peak areas above a reporting threshold. USP tailing factor T describes peak symmetry (T = W0.05 / 2f) and is a system-suitability diagnostic, not a purity result. A symmetrical peak (T near 1.0) makes the area ratio more trustworthy; a badly tailed peak can conceal related substances in the rear slope. Research documentation only.

What Rs value should a research laboratory look for on a peptide HPLC peak table?

Rs = 1.5 is the conventional threshold for baseline separation of equal-sized Gaussian peaks. Many peptide SST specifications use Rs ≥ 2.0 for the critical pair (main peak and nearest related substance). Always confirm which two peaks the CDS used and inspect valley depth on the chromatogram. A large Rs to a solvent peak does not substitute for resolution of the nearest impurity. Research use only.

Why might laboratory peptide documentation omit T, N, Rs and k′?

Many vendor PDFs transcribe only peak name, retention time and area percent from the CDS. The USP-style columns exist in the native report but are dropped when the certificate is summarised. Australian laboratories should specify those columns at purchase so that laboratory peptide documentation includes evidence of system suitability, not only a headline purity percentage.

How does lot traceability relate to reading HPLC results in Australia?

T, N, Rs and k′ are meaningless if the chromatogram is not from the vial on the bench. Match lot numbers across the vial label, COA header, HPLC sequence sample name and tracked-dispatch packing slip before copying any peak-table value into a notebook. Local Australian stock makes that cross-check practical because the physical lot and the PDF arrive together.

Can mass spectrometry replace HPLC USP peak-table fields on a COA?

No. Mass data confirm identity and can flag mass-shifted related substances, but they do not measure peak symmetry, column efficiency or chromatographic resolution. Area-percent purity remains a chromatographic integral. Orthogonal mass spectrometry complements T, N, Rs and k′; it does not replace them in laboratory peptide documentation.

What should an Australian laboratory archive with a peptide HPLC COA?

Archive the peak table (including T, N, Rs and k′), the chromatogram PDF, SST limits and chromatograms, processing-method version, instrument method (column, gradient, wavelength, load volume) and lot identifiers tied to tracked dispatch. A screenshot without a peak table is not an auditable record.

References

  1. DOI:10.1002/asi.5090180408 — Suggestions on how to read experimental material in information science — American Documentation — 1967
  2. DOI:10.5694/j.1326-5377.1992.tb137249.x — 13. How to read a journal article — Medical Journal of Australia — 1992
  3. DOI:10.3897/tdwgproceedings.1.19941 — Documentation about Atlas of Living Australia tools: how to find information — Proceedings of TDWG — 2017
  4. DOI:10.5840/acpq199569241 — How (Not) To Read Heidegger — American Catholic Philosophical Quarterly — 1995
  5. DOI:10.7816/ulakbilge-05-15-06 — HOW TO BE READ PIAAC RESULTS FOR ADAPTATION TO NEW AGE? — Ulakbilge Dergisi — 2017
  6. DOI:10.5840/acpq201488110 — Socrates and the Gods: How to Read Plato's Euthyphro, Apology and Crito. By Nalin Ranasinghe — American Catholic Philosophical Quarterly — 2014

Research use only

This article is provided for laboratory research and educational purposes only. Products referenced are not for human or veterinary use. ClaraScience makes no therapeutic, medical, or efficacy claims, and nothing here constitutes medical advice.